Sodium Oligomannate is named as a drug or biological intervention in 3 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Green Valley (Shanghai) Pharmaceuticals Co., Ltd. (2) and Nanfang Hospital, Southern Medical University (1). Registered phases: Phase 4 and Not applicable. Conditions studied include Alzheimer Disease; Ischemic Stroke.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT05545605 | Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI (ClinicalTrials.gov ↗) Ischemic Stroke |
Not applicable | Recruiting |
| NCT05058040 | A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) (ClinicalTrials.gov ↗) Alzheimer Disease |
Phase 4 | Active, closed |
| NCT05181475 | Long-term Efficacy and Safety Study of GV-971 (ClinicalTrials.gov ↗) Alzheimer Disease |
Phase 4 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Alzheimer Disease | 2 |
| Ischemic Stroke | 1 |
| Lead sponsor | Trials |
|---|---|
| Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 2 |
| Nanfang Hospital, Southern Medical University | 1 |
| Register | Sodium Oligomannate trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Sodium Oligomannate works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Sodium Oligomannate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.